Evaluation of Intra-corneal Injection of 5% Natamycin for the Treatment of Fusarium Keratitis
description
Transcript of Evaluation of Intra-corneal Injection of 5% Natamycin for the Treatment of Fusarium Keratitis
![Page 1: Evaluation of Intra-corneal Injection of 5% Natamycin for the Treatment of Fusarium Keratitis](https://reader036.fdocuments.net/reader036/viewer/2022062408/5681406f550346895dabf04e/html5/thumbnails/1.jpg)
EVALUATION OF INTRA-CORNEAL INJECTION OF 5% NATAMYCIN FOR
THE TREATMENT OF FUSARIUM KERATITIS
Fani Segev MD, Guy Tam MD, Yossi Paitan PhD, Dvora Kidron MD
Department of Ophthalmology, Microbiology & Pathology, Meir General Hospital, Kfar-Saba,
Sackler School of Medicine, Tel Aviv University, Israel
![Page 2: Evaluation of Intra-corneal Injection of 5% Natamycin for the Treatment of Fusarium Keratitis](https://reader036.fdocuments.net/reader036/viewer/2022062408/5681406f550346895dabf04e/html5/thumbnails/2.jpg)
DISCLOSURES
The authors have no financial interest in the subject matter of this poster
![Page 3: Evaluation of Intra-corneal Injection of 5% Natamycin for the Treatment of Fusarium Keratitis](https://reader036.fdocuments.net/reader036/viewer/2022062408/5681406f550346895dabf04e/html5/thumbnails/3.jpg)
INTRODUCTION
Fungal keratitis represents a serious ophthalmic infection.
If untreated, it can lead to serious complications such as endophthalmitis, perforation and blindness.
Globally, the incidence of fungal keratitis is rising due to: Use of topical steroids Use of long -term contact lenses Increase in surgical corneal procedures
Filamentous fungi (Fusarium and Asppergillus) form the major etiologic agents of fungal keratitis.
Fungal keratitis is treated with topical antifungal agents and in severe cases with combination of oral antifungal agent.
Most of the medications have limited effectiveness, absorbs poorly, and have low potency.
![Page 4: Evaluation of Intra-corneal Injection of 5% Natamycin for the Treatment of Fusarium Keratitis](https://reader036.fdocuments.net/reader036/viewer/2022062408/5681406f550346895dabf04e/html5/thumbnails/4.jpg)
OBJECTIVE
To compare the efficacy of intra-stromal
injection of Natamycin 5% combined with
topical Natamycin 5% to a standard
therapy (Natamycin 5%) in a rabbit model
of Fusarium keratitis.
![Page 5: Evaluation of Intra-corneal Injection of 5% Natamycin for the Treatment of Fusarium Keratitis](https://reader036.fdocuments.net/reader036/viewer/2022062408/5681406f550346895dabf04e/html5/thumbnails/5.jpg)
METHODS
A prospective randomized case control study
Keratitis was induced in eyes of 12 NZ rabbits by intra-stromal injection of 1.6x105 CFU/0.1ml of Fusarium spore suspension into the central cornea
![Page 6: Evaluation of Intra-corneal Injection of 5% Natamycin for the Treatment of Fusarium Keratitis](https://reader036.fdocuments.net/reader036/viewer/2022062408/5681406f550346895dabf04e/html5/thumbnails/6.jpg)
METHODS – CONT.
Rabbits were randomly divided into two groups: Group 1: received intra-stromal injection of Natamycin 5% on treatment day 1
and 4 combined with topical Natamycin 5% eye-drops given hourly for the first 2 days followed by 4 times daily on days 3-11.
Group 2: received only topical Natamycin 5% at identical interval.
Eyes were examined clinically on treatment days 1,4,7 and 11.
Extent of keratitis was graded by the following parameters: size of corneal infiltration and epithelial defect conjunctival hyperemia corneal clouding corneal neovascularization hypopion level
![Page 7: Evaluation of Intra-corneal Injection of 5% Natamycin for the Treatment of Fusarium Keratitis](https://reader036.fdocuments.net/reader036/viewer/2022062408/5681406f550346895dabf04e/html5/thumbnails/7.jpg)
RESULTS
Fusarium keratitis with hypopion developed in all eyes 4 days after intra-stromal inoculation.
In both treatment groups, clinical improvement of keratitis was recorded.
Infiltration size was statistically smaller in the intra-stromal injected group (P=0.023).
Neovascularization was statistically smaller in the control group (P=0.032).
![Page 8: Evaluation of Intra-corneal Injection of 5% Natamycin for the Treatment of Fusarium Keratitis](https://reader036.fdocuments.net/reader036/viewer/2022062408/5681406f550346895dabf04e/html5/thumbnails/8.jpg)
Clinical Scores during Follow-Up
![Page 9: Evaluation of Intra-corneal Injection of 5% Natamycin for the Treatment of Fusarium Keratitis](https://reader036.fdocuments.net/reader036/viewer/2022062408/5681406f550346895dabf04e/html5/thumbnails/9.jpg)
Clinical Course by Day
![Page 10: Evaluation of Intra-corneal Injection of 5% Natamycin for the Treatment of Fusarium Keratitis](https://reader036.fdocuments.net/reader036/viewer/2022062408/5681406f550346895dabf04e/html5/thumbnails/10.jpg)
Clinical Course
GROUP 1 GROUP 2
![Page 11: Evaluation of Intra-corneal Injection of 5% Natamycin for the Treatment of Fusarium Keratitis](https://reader036.fdocuments.net/reader036/viewer/2022062408/5681406f550346895dabf04e/html5/thumbnails/11.jpg)
CONCLUSIONS
Intra-stromal injection of Natamycin 5% combined with topical Natamycin 5% is an effective treatment modality for Fusarium keratitis.